Category Archives: People

ProKidney Appoints Kenneth Locke as Chief Technical Officer

Kenneth Locke joins as Chief Technical Officer, bringing more than 25 years of experience across Chemistry, Manufacturing and Controls (CMC) and Supply Chain as ProKidney progresses toward the potential commercialization of rilparencel WINSTON-SALEM, N.C., June 02, 2026 (GLOBE NEWSWIRE) — ProKidney Corp. (Nasdaq: PROK) (“ProKidney” or the “Company”), a leading late clinical-stage cell therapy company […]

SpyGlass Pharma Appoints Mike Pinder as Vice President, Marketing

ALISO VIEJO, Calif., June 02, 2026 (GLOBE NEWSWIRE) — SpyGlass Pharma, Inc. (Nasdaq: SGP) (SpyGlass Pharma), a late-stage biopharmaceutical company, today announced the appointment of Mike Pinder as vice president, marketing. Mr. Pinder brings over 20 years of commercial launch experience in ophthalmology, focused on building, launching, and evolving significant brands, notably in the buy-and-bill […]

Crestpoint Real Estate Investments, Vestcor & Anthem Properties Break Ground on King + Park, the New Masterplan Development at The Gateway to Burnaby

BURNABY, British Columbia, June 01, 2026 (GLOBE NEWSWIRE) — Crestpoint Real Estate Investments and Anthem Properties were joined by the Mayor of Burnaby and other guests today, to celebrate the ceremonial groundbreaking for King + Park, a landmark mixed-use masterplan that will reshape the gateway to Burnaby and deliver one of Metro Vancouver’s most ambitious […]

Microchip Provides Data Center Solutions Business Unit Revenue Information

Our Data Center Solutions Business Unit generated $302.7 million in revenue in calendar year 2025, with approximately 65% growth expected in calendar year 2026 to approximately $500 million Our broader total Datacenter and Compute end market which also includes power management, catalog MCUs, analog and security products represented approximately 18% of total revenue CHANDLER, Ariz., […]

Gumitide Gummies [SHOCKING REPORT 2026] Gumitide BREAKING INVESTIGATION Viral Weight-Loss Supplement, Counterfeit Market Risks, Customer Complaints, and Safety Analysis

Discover the truth behind Gumitide Gummies in 2026. Our investigation explores viral weight-loss claims, fake product concerns, customer experiences, ingredient analysis, and growing safety questions. New York City, NY, June 01, 2026 (GLOBE NEWSWIRE) — The dietary supplement industry continues to evolve at a rapid pace in 2026, driven by changing consumer preferences, increasing interest […]

Get Outdoors (GO!) literacy and exercise program ties in with America’s 250th anniversary

York, Pa., June 01, 2026 (GLOBE NEWSWIRE) — For the 19th consecutive summer, WellSpan and local libraries across Central Pennsylvania are launching an interactive, outdoor scavenger hunt designed to exercise the body and mind known as the Get Outdoors, or GO! program. This year, to align with the commemoration of the 250th anniversary of the […]

Nxera’s Vamorolone Granted Key Regulatory Designations Supporting Faster Access for Duchenne Muscular Dystrophy Patients in South Korea

Orphan Drug Designation (ODD) recognizes Duchenne muscular dystrophy as a rare disease with significant unmet medical need without an established treatment in South Korea. Global Innovative Products on Fast Track (GIFT) designation, a priority review pathway introduced by Korea’s Ministry of Food and Drug Safety, may support accelerated regulatory review and faster patient access to […]

SafeSpace Global Expands AI-powered Physical Safety Footprint Through Successful Integration with 911inform, the Nation’s Leading Emergency Response Platform

Combined platform unifies multimodal AI-powered physical threat detection with patented emergency response technology, creating real-time situational intelligence across K-12 schools, and senior living. KNOXVILLE, June 01, 2026 (GLOBE NEWSWIRE) — SafeSpace Global Corporation (OTCID: SSGC) (SafeSpace, SafeSpace Global or the Company), a leader in multimodal AI-powered physical safety and security solutions, today announced that pursuant […]

Rakovina Therapeutics Announces Q1 2026 Financial Results and Provides Corporate Update

All dollar amounts reflected in Canadian dollars unless otherwise stated. VANCOUVER, British Columbia, June 01, 2026 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing innovative cancer therapies through AI-powered drug discovery, today announced its financial results for the three months ended March 31, 2026 (“Q1 2026”), and provided an […]